Cesca Therapeutics Announces Evaluation Agreement With The University Of North Carolina Lineberger Advanced Cellular Therapeutics Facility for X-Series
Alder BioPharmaceuticals Presents New 12-Month Data of Eptinezumab in PROMISE 1 Phase 3 Trial Showing Long-Term Reduction in Episodic Migraine
Immunovaccine and Incyte Expand Clinical Collaboration Evaluating Combination Immunotherapies in Advanced Recurrent Ovarian Cancer
Macarthur Minerals Accelerates Development and Exploration of Its Iron Ore, Gold, Nickel and Lithium Projects
Isodiol International Inc. Announces the Launch of 3 New Cannabidiol (CBD) Product Categories with Level Brands Inc.
HashChain Technology Enters Agreement Increasing Total Purchased Rigs to 4870 Equivalent of 7 Megawatts
BIG Blockchain Intelligence Group Enters Into Agreement With Crypto Financial Services Provider Coinme, Inc. to Provide Cryptocurrency Transaction Risk-Scoring Via BitRank Verification Services(tm)
Contractor Confirmed for Large Drill Program Planned for Resource Update at Werner Lake Cobalt Project
San Antonio Endovascular & Heart Institute First to Deploy Biotricity’s New Bioflux Remote Monitoring Device
Innovation Pharmaceuticals Signs Drug Supply Contract with Evonik to Bulk Produce Commercial-Grade Brilacidin
UTHealth in Houston and Athersys Announce Funding for Clinical Trial using MultiStem® to Treat Trauma Patients
Intrinsyc Announces New Design Wins for Embedded Computing Modules to Power Innovative Medical Devices
AzurRx BioPharma and Mayoly-Spindler Announce Additional Positive Interim Data for MS1819-SD Phase II
HashChain Technology Confirms There are no Material Changes to the Recent Increase in Market Activity